Response to neoadjuvant targeted therapy in operable head and neck cancer confers survival benefit

M. Mascarella, T. Olonisakin, P. Rumde, V. Vendra, M. Nance, S. Kim, M. Kubik, S. Sridharan, R. Ferris, F. Moon, D. Clayburgh, J. Ohr, S. Joyce, M. Sen, J. Herman, J. Grandis, D. Zandberg, U. Duvvuri

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)S128
JournalEuropean Journal of Cancer
StatePublished - Oct 2022

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this